Incyte Future Growth
Future criteria checks 3/6
Incyte is forecast to grow earnings and revenue by 18.8% and 8.6% per annum respectively. EPS is expected to grow by 18.7% per annum. Return on equity is forecast to be 18.8% in 3 years.
Key information
18.8%
Earnings growth rate
18.7%
EPS growth rate
Biotechs earnings growth | 19.6% |
Revenue growth rate | 8.6% |
Future return on equity | 18.8% |
Analyst coverage | Good |
Last updated | 29 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 5,056 | 1,220 | 1,366 | 1,517 | 17 |
12/31/2025 | 4,588 | 991 | 1,118 | 1,250 | 20 |
12/31/2024 | 4,125 | 797 | 909 | 1,190 | 21 |
12/31/2023 | 3,696 | 598 | 449 | 496 | N/A |
9/30/2023 | 3,609 | 425 | 566 | 632 | N/A |
6/30/2023 | 3,513 | 366 | 698 | 781 | N/A |
3/31/2023 | 3,470 | 324 | 561 | 649 | N/A |
12/31/2022 | 3,395 | 341 | 892 | 970 | N/A |
9/30/2022 | 3,331 | 876 | 711 | 802 | N/A |
6/30/2022 | 3,320 | 945 | 665 | 760 | N/A |
3/31/2022 | 3,115 | 933 | 609 | 759 | N/A |
12/31/2021 | 2,986 | 949 | 568 | 749 | N/A |
9/30/2021 | 2,913 | 535 | 543 | 741 | N/A |
6/30/2021 | 2,721 | 338 | 450 | 668 | N/A |
3/31/2021 | 2,703 | 478 | 569 | 765 | N/A |
12/31/2020 | 2,667 | -296 | -312 | -125 | N/A |
9/30/2020 | 2,457 | -335 | -266 | -100 | N/A |
6/30/2020 | 2,388 | -191 | -108 | -12 | N/A |
3/31/2020 | 2,229 | -376 | -227 | -128 | N/A |
12/31/2019 | 2,159 | 447 | 633 | 711 | N/A |
9/30/2019 | 2,108 | 405 | 589 | 663 | N/A |
6/30/2019 | 2,006 | 306 | 476 | 592 | N/A |
3/31/2019 | 1,997 | 253 | 392 | 471 | N/A |
12/31/2018 | 1,882 | 109 | 263 | 336 | N/A |
9/30/2018 | 1,798 | -109 | 90 | 163 | N/A |
6/30/2018 | 1,729 | -102 | -66 | 17 | N/A |
3/31/2018 | 1,534 | -167 | -1 | 101 | N/A |
12/31/2017 | 1,536 | -313 | -204 | -93 | N/A |
9/30/2017 | 1,419 | -155 | N/A | 91 | N/A |
6/30/2017 | 1,306 | -154 | N/A | 133 | N/A |
3/31/2017 | 1,226 | -107 | N/A | 34 | N/A |
12/31/2016 | 1,106 | 104 | N/A | 305 | N/A |
9/30/2016 | 1,023 | 151 | N/A | 280 | N/A |
6/30/2016 | 941 | 74 | N/A | 193 | N/A |
3/31/2016 | 858 | 49 | N/A | 189 | N/A |
12/31/2015 | 754 | 7 | N/A | 89 | N/A |
9/30/2015 | 634 | -86 | N/A | 61 | N/A |
6/30/2015 | 644 | 13 | N/A | 81 | N/A |
3/31/2015 | 581 | -33 | N/A | 53 | N/A |
12/31/2014 | 511 | -48 | N/A | 26 | N/A |
9/30/2014 | 485 | -54 | N/A | -30 | N/A |
6/30/2014 | 372 | -136 | N/A | -70 | N/A |
3/31/2014 | 374 | -101 | N/A | -47 | N/A |
12/31/2013 | 355 | -83 | N/A | 9 | N/A |
9/30/2013 | 372 | -21 | N/A | -1 | N/A |
6/30/2013 | 347 | -21 | N/A | -16 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0J9P's forecast earnings growth (18.8% per year) is above the savings rate (1.6%).
Earnings vs Market: 0J9P's earnings (18.8% per year) are forecast to grow faster than the UK market (12.3% per year).
High Growth Earnings: 0J9P's earnings are forecast to grow, but not significantly.
Revenue vs Market: 0J9P's revenue (8.6% per year) is forecast to grow faster than the UK market (3.4% per year).
High Growth Revenue: 0J9P's revenue (8.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0J9P's Return on Equity is forecast to be low in 3 years time (18.8%).